MDT

95.97

-0.18%↓

136.48

+0.21%↑

VEEV

219.11

-1.79%↓

HQY

91.01

-0.55%↓

PHR.US

16.33

-3.37%↓

MDT

95.97

-0.18%↓

136.48

+0.21%↑

VEEV

219.11

-1.79%↓

HQY

91.01

-0.55%↓

PHR.US

16.33

-3.37%↓

MDT

95.97

-0.18%↓

136.48

+0.21%↑

VEEV

219.11

-1.79%↓

HQY

91.01

-0.55%↓

PHR.US

16.33

-3.37%↓

MDT

95.97

-0.18%↓

136.48

+0.21%↑

VEEV

219.11

-1.79%↓

HQY

91.01

-0.55%↓

PHR.US

16.33

-3.37%↓

MDT

95.97

-0.18%↓

136.48

+0.21%↑

VEEV

219.11

-1.79%↓

HQY

91.01

-0.55%↓

PHR.US

16.33

-3.37%↓

Strona główna・Stock List・Fortrea Holdings Inc.

Fortrea Holdings Inc.

Open

SectorHealthcare

16.38 -4.66

Buy Sell

Overview

Share price change

24h

Current

Min

16.14

Max

17.08

Key metrics
By Trading Economics
Income	359M -16M
Sales	-9M 701M
EPS	0.12
Profit margin	-2.267
Employees	14,500
EBITDA	341M 14M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	-24.64% downside

Market Stats
By TradingEconomics
Market Cap	675M 1.6B
Previous open	21.04
Previous close	16.38

News Sentiment

By Acuity

50%

141 / 374 Ranking in Healthcare

Fortrea Holdings Inc. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 gru 2025, 22:20 UTC

Major Market Movers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 gru 2025, 17:31 UTC

Major Market Movers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 gru 2025, 16:30 UTC

Major Market Movers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 gru 2025, 15:19 UTC

Major Market Movers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 gru 2025, 15:17 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 gru 2025, 14:37 UTC

Major Market Movers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 sty 2026, 23:35 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

1 sty 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 sty 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope Sold Stake in JV to Tata Steel

1 sty 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 sty 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 sty 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 gru 2025, 21:13 UTC

Acquisitions, Mergers, Takeovers

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 gru 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 gru 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 gru 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 gru 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 gru 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 gru 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 gru 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 gru 2025, 17:16 UTC

Major Market Movers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 gru 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 gru 2025, 17:00 UTC

Acquisitions, Mergers, Takeovers

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 gru 2025, 15:57 UTC

Acquisitions, Mergers, Takeovers

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 gru 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 gru 2025, 15:02 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 gru 2025, 14:40 UTC

Acquisitions, Mergers, Takeovers

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 gru 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 gru 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Comparison

Price change

Fortrea Holdings Inc. Forecast

Price Target

By TipRanks

-24.64% downside

12 Months Forecast

Average 13 USD -24.64%

High 21 USD

Low 7 USD

Based on 8 Wall Street analysts offering 12 month price targets forFortrea Holdings Inc. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Fortrea Holdings Inc. - Dist in the past 3 months.

Sentiment

By Acuity

141 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.